FindTrial
Sign In

Use of soyabean in the management of menopausal symptoms

STUDY THE EFFICACY OF SOYA BEAN (GLYCINE MAX) IN THE MANAGEMENT OF MENOPAUSAL SYNDROME

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025143
Enrollment
90
Registered
2020-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SOYABEAN(Glycin max): GERMINATED SOYABEAN(glycin max) CONSUMPTION IN THE DOSE OF 75 GRAMS TWO TIMES A DAY PREFERABLY EMPTY STOMACH Control Intervention1: NIL: NIL

Sponsors

Bharati Vidyapeeth Deemed to be University College of Ayurved Dhankawadi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing signs and symptoms of menopausal syndrome 2. Menopausal women not taking HRT

Exclusion criteria

Exclusion criteria: 1. Patients having any type of malignancy. 2. Prolapsed uterus. 3. Major neurologic condition such as stroke 4. Patients with severe gynecological disorders. 5. Patients having systemic illnesses such as diabetes mellitus, metabolic syndrome, hypertension

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms resulting in prevention of complications related to menopausal syndrome.Timepoint: 3 Months—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDR MRS KIRTI BHATI

Bharati Vidyapeeth (Deemed to be) University College of Ayurved, Dhankawadi,Pune-43

VELHALAMOL@GMAIL.COM9175403402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026